CCG
TMO icon

Chatham Capital Group’s Thermo Fisher Scientific TMO Stock Holding History

Chatham Capital Group’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-457
Closed -$305K – 192
2021
Q4 		$305K Hold
457
– – 0.06% 164
2021
Q3 		$261K Hold
457
– – 0.05% 168
2021
Q2 		$231K Buy
+457
New +$216K 0.04% 179

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Chatham Capital Group's TMO Position: Q1 2022 in Review

Chatham Capital Group sold out of Thermo Fisher Scientific (TMO) in Q1 2022, closing a stake of 457 shares — an estimated $305K sold.

Chatham Capital Group first reported a position in TMO in Q2 2021 and held it in 3 quarters. The position peaked at $305K in Q4 2021. 2,314 funds tracked by Wall St. Rank hold TMO as of Q1 2022.

  • Chatham Capital Group reported no remaining Thermo Fisher Scientific position as of Q1 2022 after selling out during the quarter.
  • Chatham Capital Group sold 457 Thermo Fisher Scientific shares in Q1 2022, an estimated $305K.
  • Chatham Capital Group first reported a position in Thermo Fisher Scientific in Q2 2021 and held it in 3 quarters.
  • Chatham Capital Group's Thermo Fisher Scientific position peaked at $305K in Q4 2021.
  • 2,314 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2022.

Based on Chatham Capital Group's 13F filing for Q1 2022, filed 21 Apr 2022.